Use of a concentrate immunoglobulin G (IgG) depleted maternal-fetus ABO anti-A and anti-B for the treatment of neonatal jaundice incompatibility antibodies

摘要

Composition immunoglobulin G (IgG) for therapeutic use, comprising respective titers of anti-A and anti-B line with a negative test result indirect Coombs (method 2.6.20 of the European Pharmacopoeia) for use in the treatment of neonatal jaundice fetomaternal incompatibility ABO or hemolytic disease of the newborn ABO.